Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse. (2018)
Attributed to:
Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2147/idr.s156581
PubMed Identifier: 30127629
Publication URI: http://europepmc.org/abstract/MED/30127629
Type: Journal Article/Review
Volume: 11
Parent Publication: Infection and drug resistance
ISSN: 1178-6973